中西医协同治疗重症急性胰腺炎的进展述评

谢胜; 严静; 黎丽群; 王光耀; 刘礼剑

doi:10.3969/j.issn.1671-038X.2024.02.02

中西医协同治疗重症急性胰腺炎的进展述评

- 1.
  广西中医药大学第一附属医院脾胃病科(南宁，530023)
- 2.
  广西中医药大学研究生院
基金项目:
广西重点研发项目(No：桂科AB23026098);国家中医药管理局高水平中医药重点学科建设项目(No：zyyzdxk-2023167); 广西中医药重点研究室建设项目(No：桂中医药科教发〔2023〕9号); 广西岐黄学者培养项目(No：2022015-003-01)

详细信息

作者简介:
谢胜，教授，主任医师，二级专业技术岗，博士研究生导师，博士后合作导师。第二届桂派中医大师，第七批全国老中医药专家学术经验继承工作指导老师。现任广西中医药大学第一附属医院院长，兼任国家中医药管理局中医药高水平重点学科中医养生学项目负责人、国家中医药管理局中西医结合临床重点学科带头人、国家卫生健康委脾胃病临床重点专科带头人、国家中医药管理局脾胃病重点专科带头人。兼任中国民族医药学会脾胃病分会会长、中华中医药学会脾胃病分会副主任委员、世界中医药联合会消化病分会副会长，中华中医药学会治未病分会副主任委员、中国医师协会中医师分会副会长等。担任《中国中西医结合消化杂志》副主编，主持完成国家自然基金项目4项，省部级项目10项，发表论文243篇，主编著作7部，获专利10项，软件著作权2件，获广西科学技术进步类一等奖1项，中国民族医药学会科学技术奖一等奖2项。获第六届“中国医师奖”、第五届“人民名医·卓越建树奖”

通讯作者: 谢胜，E-mail：xsh6566@163.com

中图分类号: R256.35

收稿日期: 2023-12-25

刊出日期: 2024-02-15

A review on the progress of Chinese and Western medicine in the treatment of severe acute pancreatitis

- 1.
  Department of Gastroenterology, the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, 530023, China
- 2.
  Graduate School of Guangxi University of Traditional Chinese Medicine

More Information

Corresponding author: XIE Sheng, E-mail: xsh6566@163.com

Received Date: 25 December 2023

Publish Date: 15 February 2024

摘要

摘要: 重症急性胰腺炎(severe acute pancreatitis，SAP)是急性胰腺炎(acute pancreatitis，AP)最严重的一种类型，常伴发全身炎症反应综合征以及多脏器功能衰竭。本病致病因素十分复杂，发病机制尚不完全明确，具有起病急、进展快、并发症多、治疗时间长、致死率高等特点。单纯使用中药或西药治疗仍难以完全控制疾病进展及改善预后，中西医协同在SAP治疗中显示一定优势。本文对近些年来中西医协同治疗SAP的研究进行归纳总结，结合西医发病机制、中医病机和中西医治疗研究现状等予以探讨，并浅析基于中西医病机融通下SAP中西医协同治疗的切入点，证实中西医协同治疗SAP具有合理性、可靠性、有效性、发展性等优势。未来进一步努力探索SAP的中西医协同治疗当是颇具价值的研究方向。
- 重症急性胰腺炎 /
- 中西医协同 /
- 进展 /
- 述评
Abstract: Severe acute pancreatitis(SAP) is the most serious type of acute pancreatitis(AP), which is often accompanied by systemic inflammatory response syndrome and multiple organ failure. The pathogenic factors of this disease are very complex, and the pathogenesis is not completely clear. It has the characteristics of acute onset, rapid progress, many complications, long treatment time and high mortality. It is still difficult to completely control the disease progression and improve the prognosis by using traditional Chinese medicine or Western medicine alone. The combination of traditional Chinese and Western medicine shows certain advantages in the treatment of SAP. This article summarizes the research on the collaborative treatment of SAP with traditional Chinese and Western medicine in recent years, discusses the pathogenesis of Western medicine, the pathogenesis of traditional Chinese medicine and the research status of traditional Chinese and Western medicine treatment, and analyzes the entry point of SAP collaborative treatment of traditional Chinese and Western medicine based on the integration of traditional Chinese and Western medicine pathogenesis. It is confirmed that the collaborative treatment of SAP with traditional Chinese and Western medicine has the advantages of rationality, reliability, effectiveness and development. In the future, it is a valuable research direction to further explore the synergistic treatment of SAP with Chinese and Western medicine.
- severe acute pancreatitis /
- Chinese and Western medicine collaboration /
- progress /
- commentary

HTML全文

参考文献(54)

[1]	Ghitǎ AI, Pahomeanu MR, Negreanu L. Epidemiological trends in acute pancreatitis: A retrospective cohort in a tertiary center over a seven year period[J]. World J Methodol, 2023, 13(3): 118-126. doi: 10.5662/wjm.v13.i3.118
[2]	Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis[J]. Lancet, 2020, 396(10252): 726-734. doi: 10.1016/S0140-6736(20)31310-6
[3]	李非, 曹锋. 中国急性胰腺炎诊治指南(2021)[J]. 中国实用外科杂志, 2021, 41(7): 739-746.
[4]	Tang D, Gu J, Ao Y, et al. Clinical efficacy of endoscopic retrograde cholangiopancreatography in the treatment of acute biliary pancreatitis: a meta-analysis[J]. Wideochir Inne Tech Maloinwazyjne, 2022, 17(4): 561-578.
[5]	Mederos MA, Reber HA, Girgis MD. Acute Pancreatitis: A Review[J]. JAMA, 2021, 325(4): 382-390. doi: 10.1001/jama.2020.20317
[6]	Matta B, Gougol A, Gao X, et al. Worldwide Variations in Demographics, Management, and Outcomes of Acute Pancreatitis[J]. Clin Gastroenterol Hepatol, 2020, 18(7): 1567-1575. e2. doi: 10.1016/j.cgh.2019.11.017
[7]	Zeng Q, Xu J, Mu X, et al. Safety issues of tirzepatide(pancreatitis and gallbladder or biliary disease)in type 2 diabetes and obesity: a systematic review and meta-analysis[J]. Front Endocrinol(Lausanne), 2023, 14: 1214334. doi: 10.3389/fendo.2023.1214334
[8]	Zerem E, Kurtcehajic A, Kunosic S, et al. Current trends in acute pancreatitis: Diagnostic and therapeutic challenges[J]. World J Gastroenterol, 2023, 29(18): 2747-2763. doi: 10.3748/wjg.v29.i18.2747
[9]	Mareninova OA, Gretler SR, Lee GE, et al. Ethanol inhibits pancreatic acinar cell autophagy through upregulation of ATG4B, mediating pathological responses of alcoholic pancreatitis[J]. Am J Physiol Gastrointest Liver Physiol, 2023, 325(3): G265-G278. doi: 10.1152/ajpgi.00053.2023
[10]	Deng J, Song Z, Li X, et al. Role of lncRNAs in acute pancreatitis: pathogenesis, diagnosis, and therapy[J]. Front Genet, 2023, 14: 1257552. doi: 10.3389/fgene.2023.1257552
[11]	Fu X, Xiu Z, Xu H. Interleukin-22 and acute pancreatitis: A review[J]. Medicine(Baltimore), 2023, 102(44): e35695.
[12]	Jin H, Zhao K, Li J, et al. Matrine alleviates oxidative stress and ferroptosis in severe acute pancreatitis-induced acute lung injury by activating the UCP2/SIRT3/PGC1α pathway[J]. Int Immunopharmacol, 2023, 117: 109981. doi: 10.1016/j.intimp.2023.109981
[13]	Wang Z, Guo M, Li J, et al. Composition and functional profiles of gut microbiota reflect the treatment stage, severity, and etiology of acute pancreatitis[J]. Microbiol Spectr, 2023, 11(5): e0082923. doi: 10.1128/spectrum.00829-23
[14]	Yu S, Xiong Y, Xu J, et al. Identification of Dysfunctional Gut Microbiota Through Rectal Swab in Patients with Different Severity of Acute Pancreatitis[J]. Dig Dis Sci, 2020, 65(11): 3223-3237. doi: 10.1007/s10620-020-06061-4
[15]	Siregar GA, Siregar GP. Management of Severe Acute Pancreatitis[J]. Open Access Maced J Med Sci, 2019, 7(19): 3319-3323. doi: 10.3889/oamjms.2019.720
[16]	Wen Y, Xu L, Zhang D, et al. Effect of early antibiotic treatment strategy on prognosis of acute pancreatitis[J]. BMC Gastroenterol, 2023, 23(1): 431. doi: 10.1186/s12876-023-03070-1
[17]	Zheng Z, Ding YX, Qu YX, et al. A narrative review of acute pancreatitis and its diagnosis, pathogenetic mechanism, and management[J]. Ann Transl Med, 2021, 9(1): 69. doi: 10.21037/atm-20-4802
[18]	Huang L, Zhu H, Gu J. Octreotide and Continuous Hemofiltration versus Continuous Hemofiltration Alone in Severe Acute Pancreatitis Complicated with Acute Respiratory Distress Syndrome[J]. J Coll Physicians Surg Pak, 2019, 29(8): 785-787. doi: 10.29271/jcpsp.2019.08.785
[19]	McHenry N, Shah I, Ahmed A, et al. Racial Variations in Pain Management and Outcomes in Hospitalized Patients With Acute Pancreatitis[J]. Pancreas, 2022, 51(9): 1248-1250. doi: 10.1097/MPA.0000000000002160
[20]	Almulhim M, Almulihi QA, Almumtin HS, et al. The Efficacy and Safety of Using Opioids in Acute Pancreatitis: an Update on Systematic Review and Meta-Analysis[J]. Med Arch, 2023, 77(4): 281-287. doi: 10.5455/medarh.2023.77.281-287
[21]	Wang Z, Liu J, Li F, et al. Mechanisms of Qingyi Decoction in Severe Acute Pancreatitis-Associated Acute Lung Injury via Gut Microbiota: Targeting the Short-Chain Fatty Acids-Mediated AMPK/NF-κB/NLRP3 Pathway[J]. Microbiol Spectr, 2023, 11(4): e0366422. doi: 10.1128/spectrum.03664-22
[22]	Li XY, He C, Zhu Y, et al. Role of gut microbiota on intestinal barrier function in acute pancreatitis[J]. World J Gastroenterol, 2020, 26(18): 2187-2193. doi: 10.3748/wjg.v26.i18.2187
[23]	Baron TH, DiMaio CJ, Wang AY, et al. American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis[J]. Gastroenterology, 2020, 158(1): 67-75. e1. doi: 10.1053/j.gastro.2019.07.064
[24]	Alzerwi N. Surgical management of acute pancreatitis: Historical perspectives, challenges, and current management approaches[J]. World J Gastrointest Surg, 2023, 15(3): 307-322. doi: 10.4240/wjgs.v15.i3.307
[25]	Szatmary P, Grammatikopoulos T, Cai W, et al. Acute Pancreatitis: Diagnosis and Treatment[J]. Drugs, 2022, 82(12): 1251-1276. doi: 10.1007/s40265-022-01766-4
[26]	Fostier R, Arvanitakis M, Gkolfakis P. Nutrition in acute pancreatitis: when, what and how[J]. Curr Opin Clin Nutr Metab Care, 2022, 25(5): 325-328. doi: 10.1097/MCO.0000000000000851
[27]	Carlin-Ronquillo A, Benites-Goñi H, Diaz-Arocutipa C, et al. Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis: A systematic review of randomized controlled trials[J]. Rev Gastroenterol Peru, 2023, 43(3): 207-216. doi: 10.47892/rgp.2023.433.1542
[28]	张聪, 欧亚林, 钱洪良, 等. 重症急性胰腺炎早期液体平衡对预后的影响[J]. 中华危重病急救医学, 2023, 35(5): 524-527. doi: 10.3760/cma.j.cn121430-20221020-00933
[29]	张华锋, 赵佳, 张允忠, 等. 以腹内压和氧合指数为目标终点指导重症急性胰腺炎患者液体复苏的管理[J]. 中华危重病急救医学, 2022, 34(5): 525-528. doi: 10.3760/cma.j.cn121430-20211115-01720
[30]	张声生, 李慧臻. 急性胰腺炎中医诊疗专家共识意见(2017)[J]. 临床肝胆病杂志, 2017, 33(11): 2052-2057. doi: 10.3969/j.issn.1001-5256.2017.11.002
[31]	康鸿鑫, 唐文富. 唐文富教授从厥阴病论治重症急性胰腺炎恢复期临证经验[J]. 四川中医, 2020, 38(7): 22-25.
[32]	杨昕, 秦百君, 唐曦平, 等. 清解化攻方调控HMGB1/TLR9/NF-κB信号通路对重症急性胰腺炎大鼠肠黏膜屏障保护作用的研究[J]. 时珍国医国药, 2022, 33(10): 2346-2349. doi: 10.3969/j.issn.1008-0805.2022.10.11
[33]	刘礼剑, 马超北, 刘园园, 等. 基于中西医病机融通从"痹"论治重症急性胰腺炎[J]. 时珍国医国药, 2023, 34(7): 1681-1683. doi: 10.3969/j.issn.1008-0805.2023.07.37
[34]	王卫伟, 王忠玉. 大柴胡汤联合连续血液净化治疗急性重症胰腺炎疗效及对血清生化指标、免疫功能与炎性因子的影响[J]. 现代中西医结合杂志, 2020, 29(4): 426-429. doi: 10.3969/j.issn.1008-8849.2020.04.022
[35]	Jin W, Shen Y. Da-Cheng-Qi Decoction Alleviates Intestinal Injury in Rats with Severe Acute Pancreatitis by Inhibiting the JAK2-STAT3 Signaling Pathway[J]. Evid Based Complement Alternat Med, 2019, 2019: 3909468.
[36]	张光亚, 赵云, 马栋. 大黄牡丹汤对重症急性胰腺炎大鼠肝肾功能及肝肾病理影响[J]. 四川中医, 2018, 36(11): 48-51.
[37]	朱天红, 陈本启, 赵伟, 等. 茵陈蒿汤对重症急性胰腺炎大鼠相关急性肝损伤的作用及p62-keap1-Nrf2信号通路的影响[J]. 中国中医急症, 2019, 28(7): 1167-1170. doi: 10.3969/j.issn.1004-745X.2019.07.011
[38]	赵中江, 邓哲, 孙冀武, 等. 痰热清注射液对重症急性胰腺炎大鼠肺损伤保护作用的初步研究[J]. 中国中医急症, 2015, 24(4): 604-607. doi: 10.3969/j.issn.1004-745X.2015.04.013
[39]	马丹, 包先丽, 叶霜, 等. 复方丹参注射液对重症急性胰腺炎肺损伤大鼠CYLD/NF-κB信号的影响[J]. 中国中医急症, 2018, 27(12): 2098-2102, 2119. doi: 10.3969/j.issn.1004-745X.2018.12.010
[40]	杨伟钦, 李培武, 米红, 等. 参附注射液对重症急性胰腺炎大鼠心肌的保护作用[J]. 中国实验方剂学杂志, 2018, 24(7): 159-164.
[41]	黄梦遥, 陈国忠, 郑日辉, 等. 中医常用外治法治疗重症急性胰腺炎研究进展[J]. 中国中医药信息杂志, 2023, 30(2): 178-180.
[42]	潘珍, 叶颖颖, 徐芬, 等. 生大黄鼻饲、灌肠联合中药封包外敷对重症急性胰腺炎腑实热结证患者胃肠道功能的保护作用[J]. 浙江中医杂志, 2023, 58(9): 659-660. doi: 10.3969/j.issn.0411-8421.2023.09.018
[43]	谭旭东, 张波, 张彬, 等. 足三里注射治疗重症急性胰腺炎的临床观察[J]. 世界中西医结合杂志, 2015, 10(12): 1703-1705.
[44]	李佳, 赵雨, 文谦, 等. 电针干预重症急性胰腺炎伴麻痹性肠梗阻: 随机对照研究[J]. 中国针灸, 2016, 36(11): 1126-1130.
[45]	李杰, 王萍, 乐静, 等. 针刺联合麻杏石甘汤加减对重症急性胰腺炎相关性肺损伤及外周血NGAL、TLR4的影响[J]. 中国中医急症, 2022, 31(12): 2132-2135, 2143. doi: 10.3969/j.issn.1004-745X.2022.12.015
[46]	王绍彬. 穴位艾灸治疗急性胰腺炎伴胃肠功能障碍的疗效观察[J]. 中西医结合护理(中英文), 2018, 4(2): 72-75.
[47]	郑长春, 陈建辉. 清胰汤联合生长抑素、肠内营养治疗对重症急性胰腺炎患者肠道功能和炎性因子的影响[J]. 中外医学研究, 2021, 19(15): 123-126.
[48]	黄璟, 姜爽. 消炎利胆汤联合乌司他丁治疗重症急性胰腺炎肝胆湿热证临床研究[J]. 陕西中医, 2023, 44(6): 717-720, 725.
[49]	张烨, 李春涛, 鲁蕾. 复方丹参注射液对急性胰腺炎患者凝血、炎症、氧化应激及内皮指标的影响[J]. 海南医学院学报, 2018, 24(21): 1885-1888.
[50]	王婷余, 王海双. 清下化瘀方联合早期肠内营养支持治疗重症急性胰腺炎临床研究[J]. 新中医, 2022, 54(6): 110-113.
[51]	安莹, 王宏, 闫铁静. 中药口服与保留灌肠联合生长抑素在高脂血症性重症急性胰腺炎中应用[J]. 辽宁中医杂志, 2023, 50(11): 99-102.
[52]	张英, 张建茹, 张雨, 等. 柴芩攻毒方灌肠联合电针治疗重症急性胰腺炎湿热毒瘀证35例[J]. 环球中医药, 2022, 15(6): 1091-1094.
[53]	谢胜, 刘园园, 张丽敏, 等. 从"五痹"切入探讨危急重症的中西医病机融通与组方思路[J]. 广西科学, 2022, 29(6): 1021-1025.
[54]	杜奕奇, 李维勤, 毛恩强. 中国急性胰腺炎多学科诊治共识意见[J]. 临床肝胆病杂志, 2015, 31(11): 1770-1775.